Report Feature
the future of the hematology diagnostic market looks promising with opportunities in hospitals and diagnostic labs. The global hematology diagnostic market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are development of technologically advanced hematology analyzers, increasing usage of flow cytometry in hematology testing, and development of high-sensitivity point-of-care hematology analyzers.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hematology diagnostic market report, please download the report brochure.
In this market, consumables is the largest product of hematology diagnostic, whereas hospitals is the largest end user. Growth in various segments of the hematology diagnostic market are given below:
The study includes trends and forecast for the global hematology diagnostic market by product, test, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Instrument
- Consumables
By Test [Value ($ Million) shipment analysis for 2014 – 2025]:
-
CBC
- Hemoglobin
- Hematocrit
- RBC
- WBC
- Reticulocytes
- Platelet Function
- CRP
- Neutrophil Function
- Bone Marrow
- DPG
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals
- Diagnostic Labs
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the hematology diagnostic companies profiled in this report include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Boule Diagnostics, Horiba, Mindray Medical, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare, and Sysmex Corporation.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rise in diagnosis of blood disorders and other infections and increasing test volume owing to rising awareness and early detection.
Within this market, hospitals will remain the largest end user segment over the forecast period due to high patient influx in hospitals and a growing number of registered hospitals across the globe.
North America will remain the largest region over the forecast period due to technological advancements in instruments, ease of usage, and favorable reimbursement scenario.
|
Features of the Global Hematology Diagnostic Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global hematology diagnostic market by product (instrument and consumables), test (CBC (hemoglobin, hematocrit, and RBC), WBC, reticulocytes, platelet function, CRP, neutrophil function, bone marrow, and DPG), end user (hospitals, diagnostic labs, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global hematology diagnostic market? Q.5 What are the business risks and threats to the global hematology diagnostic market? Q.6 What are the emerging trends in this hematology diagnostic market and the reasons behind them? Q.7 What are some changing demands of customers in this hematology diagnostic market? Q.8 What are the new developments in this hematology diagnostic market? Which companies are leading these developments? Q.9 Who are the major players in this hematology diagnostic market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this hematology diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global hematology diagnostic market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Instrument and Consumables), Test (CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG), and End User (Hospitals, Diagnostic Labs, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Hematology Diagnostic Market
4.1 Global Hematology Diagnostic Market by Region
4.2.1 Market by Product: Instrument and Consumables
4.2.2 Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.2.3 Market by End User: Hospitals, Diagnostic Labs, and Others
4.2.4 The United States Hematology Diagnostic Market
4.2.5 The Canadian Hematology Diagnostic Market
4.2.6 The Mexican Hematology Diagnostic Market
4.3.1 Market by Product: Instrument and Consumables
4.3.2 Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.3.3 Market by End User: Hospitals, Diagnostic Labs, and Others
4.3.4 The United Kingdom Hematology Diagnostic Market
4.3.5 The Spanish Hematology Diagnostic Market
4.3.6 The German Hematology Diagnostic Market
4.3.7 The French Hematology Diagnostic Market
4.4.1 Market by Product: Instrument and Consumables
4.4.2 Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.4.3 Market by End User: Hospitals, Diagnostic Labs, and Others
4.4.4 The Chinese Hematology Diagnostic Market
4.4.5 The Indian Hematology Diagnostic Market
4.4.6 The Japanese Hematology Diagnostic Market
4.5.1 Market by Product: Instrument and Consumables
4.5.2 Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.5.3 Market by End User: Hospitals, Diagnostic Labs, and Others
4.5.5 Brazilian Hematology Diagnostic Market
7.1.1 Growth Opportunities for the Global Hematology Diagnostic Market by Product
7.1.2 Growth Opportunities for the Global Hematology Diagnostic Market by Test
7.1.3 Growth Opportunities for the Global Hematology Diagnostic Market by End User
7.1.4 Growth Opportunities for the Global Hematology Diagnostic Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
